Table 1 Cell body diameter (μm) of pyramidal cells in the hippocampal CA1, CA2, and CA3 regions and cell body diameter (μm) of granular cells in the DG region in the different treatment groups. Data are expressed as (mean ± SD), (P < 0.05)
Groups | Cell body diameter (μm) of pyramidal cells | Cell body diameter (μm) of granular cells | ||
|---|---|---|---|---|
CA1 | CA2 | CA3 | ||
Control group | 24.22 ± 0.28 | 22.25 ± 0.43 | 24.87 ± 1.02 | 13.21 ± 0.61 |
Acrolein-treated group | 18.01 ± 0.66 | 10.12 ± 0.01 | 20.55 ± 0.27 | 9.25 ± 0.73 |
Quercetin nanoparticle- treated group | 24.62 ± 0.52 | 22.75 ± 0.53 | 24.92 ± 0.97 | 13.22 ± 0.87 |
Ameliorative group | 21.12 ± 0.23 | 20.86 ± 0.57 | 23.61 ± 0.92 | 12.64 ± 1.04 |
Protective group | 23.22 ± 0.84 | 21.72 ± 0.92 | 23.96 ± 0.44 | 12.91 ± 0.26 |
Recovery group | 20.32 ± 0.45 | 18.22 ± 0.01 | 22.21 ± 0.38 | 10.37 ± 0.02 |